(28 days)
The iTotal CR Knee Replacement System (KRS) is intended for use as a total knee replacement in patients with knee joint pain and disability whose conditions cannot be solely addressed by the use of a prosthetic device that treats only one or two of the three knee compartments, such as a unicondylar, patellofemoral or bicompartmental prosthesis.
The Indications for Use include:
· Painful joint disease due to osteoarthritis, traumatic arthritis, rheumatoid arthritis or osteonecrosis of the knee.
· Post traumatic loss of joint function.
· Moderate varus, valgus or flexion deformity in which the ligamentous structures can be returned to adequate function and stability.
· Failed osteotomies, hemiarthroplasties, and unicondylar, patellofemoral or bicompartmental implants.
· Revision procedures provided that anatomic landmarks necessary for alignment and positioning of the implant are identifiable on patient imaging scans.
This implant is intended for cemented use only.
The iTotal® CR Knee Replacement System (hereafter referred to as the "iTotal CR KRS") is a patient specific tricompartmental faceted posterior cruciate ligament (PCL) retaining knee replacement system. The iTotal® CR KRS is a semi-constrained, cemented knee implant which consists of a femoral, tibial, and patellar component.
Using patient imaging and a combination of proprietary and off the shelf software a patient specific implant is designed, that best meets the geometric and anatomic requirements of the specific patient. The femoral component is manufactured from cobalt chromium molybdenum (CoCrMo) alloy. The tibial component includes a metal tray manufactured from CoCrMo alloy and either one or two polyethylene inserts. The polyethylene inserts may be manufactured from either UHMWPE or iPoly XE™ (a highly cross-linked vitamin E infused polyethylene) The patellar component is also manufactured from either UHMWPE or iPoly XE.
For user convenience, and similar to the predicate iTotal CR KRS, patient specific accessory orthopedic manual surgical instruments designed for use with the proposed iTotal CR KRS are provided to assist in the positioning of the total knee replacement components intraoperatively and in guiding the cutting of bone. In addition, reusable orthopedic manual surgical instruments are provided separately.
The function and general design features of the patient specific implants and ancillary instruments remain similar to those described in the predicate 510(k), K160025.
The provided document is a 510(k) summary for the ConforMIS iTotal® Cruciate Retaining (CR) Knee Replacement System (iTotal CR KRS). It focuses on establishing substantial equivalence to a predicate device, specifically for an additional sterilization method (Ethylene Oxide) for certain components.
The information requested, which typically relates to the acceptance criteria and study data for device performance in relation to its intended clinical use (e.g., accuracy, sensitivity, specificity, or effects on human readers for AI/diagnostic devices), is not present in this document. This submission primarily deals with changes in manufacturing (sterilization methods) and material properties, rather than clinical efficacy or diagnostic performance. Therefore, the requested information about device performance against acceptance criteria for a "study that proves the device meets the acceptance criteria" in a clinical/diagnostic sense cannot be extracted from this text.
However, I can provide information on the acceptance criteria and supporting "study" (validation testing) related to the sterilization process as outlined in the document:
Here's the information regarding the sterilization validation:
1. Table of Acceptance Criteria and Reported Device Performance (related to sterilization)
| Acceptance Criteria | Reported Device Performance |
|---|---|
| Sterility Assurance Level (SAL) of 1.0 x 10^-6 for all components post-sterilization (VHP or Ethylene Oxide) | Meets Criteria: Sterilization Validation was performed to confirm an SAL of 1.0 x 10^-6 for all components, including those sterilized via Ethylene Oxide. The iPoly XE components, previously cleared for VHP, are now also cleared for EO sterilization to an SAL of 1.0 x 10^-6. |
| Acceptable Ethylene Oxide (EO) Residuals | Meets Criteria: EO Residual Testing was performed. (Specific residual values are not detailed, but the conclusion of substantial equivalence implies acceptable levels). |
| Retention of Mechanical, Material, and Chemical Properties Post-EO Sterilization for iPoly XE | Meets Criteria: Testing was performed to demonstrate that the iPoly XE material retains its mechanical, material, and chemical properties after EO sterilization. (Specific tests/results are not detailed, but the conclusion of substantial equivalence implies satisfactory results). |
| Non-pyrogenic status ( |
§ 888.3560 Knee joint patellofemorotibial polymer/metal/polymer semi-constrained cemented prosthesis.
(a)
Identification. A knee joint patellofemorotibial polymer/metal/polymer semi-constrained cemented prosthesis is a device intended to be implanted to replace a knee joint. The device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across-the-joint. This generic type of device includes prostheses that have a femoral component made of alloys, such as cobalt-chromium-molybdenum, and a tibial component or components and a retropatellar resurfacing component made of ultra-high molecular weight polyethylene. This generic type of device is limited to those prostheses intended for use with bone cement (§ 888.3027).(b)
Classification. Class II.